Do you provide Skin Sensitisation Assessment?

No company has listed this service yet. Add it to your company profile to be the first provider shown here.

Definition

Skin sensitisation assessment along the adverse outcome pathway

Allergic contact sensitisation develops in a sequence of biological steps, described by the OECD as an adverse outcome pathway with four key events. Each assay in this family targets one of them. A single result covers one step, so laboratories combine two or more.

Key event 1: protein binding

Most sensitisers react with skin proteins to form the complex the immune system recognises. Peptide and protein reactivity testing measures this in chemico. In the direct peptide reactivity assay (DPRA, OECD Test Guideline 442C), the substance is incubated with synthetic peptides containing cysteine or lysine, and HPLC measures how much peptide is depleted.

Key event 2: keratinocyte activation

Keratinocyte reporter assays under OECD Test Guideline 442D measure activation of the Keap1-Nrf2 stress-response pathway in a modified cell line, read by luminescence.

Key event 3: dendritic-cell activation

Dendritic-cell activation testing exposes monocytic cell lines such as THP-1 to the substance and measures surface markers CD86 and CD54 by flow cytometry, as in the h-CLAT under OECD Test Guideline 442E. A sensitisation cytokine panel adds measurement of released signalling proteins.

Key event 4: T-cell response

T-cell studies for skin sensitisation examine whether the substance primes or activates T lymphocytes from human donors. They are specialised assays used to investigate mechanism and potency.

Combining the data

OECD Guideline 497 sets out defined approaches, such as the 2-out-of-3 approach, that turn results from several assays into a hazard call. The final report states the prediction, the assays behind it and any potency category.

Services in Skin Sensitisation Assessment

0 companies 0 services
0 companies 0 services
0 companies 0 services
0 companies 0 services
Applications

Choosing assays for skin sensitisation assessment

The right assay set depends on what the ingredient is, what is already known about it and how the result will be used.

Standard battery or targeted follow-up

For a new ingredient that needs a hazard conclusion, the usual starting point is one assay from each of the first three key events, run in parallel or in sequence, and combined in a defined approach. A 2-out-of-3 design can stop after two concordant results, which saves time and cost. Cytokine panels and T-cell studies come in when you need more detail on mechanism or potency, for instance when an ingredient gives mixed results or when your safety assessor wants a stronger basis for a use concentration.

Material properties that guide the choice

Solubility decides which assays can run, since every method needs the substance dissolved at its test concentrations. Pre-haptens and pro-haptens, which become reactive only after oxidation or metabolism, can be missed by peptide reactivity alone, so cell-based assays carry more weight for them. Complex botanical extracts and mixtures sit at the edge of most methods’ scope. Share the material’s chemistry, purity and solubility with the laboratory before it proposes a design. Cytotoxicity data help set test concentrations for the cell-based assays.

Where results go next

The hazard and potency conclusion feeds the toxicological safety assessment, which sets an acceptable concentration in the finished product. The same data underpin a hypoallergenic claim assessment and give the basis for later repeat-insult patch testing on volunteers.

Exploration

More in In Vitro & In Chemico Safety Testing

In vitro and in chemico safety testing uses cell cultures, tissue models and chemical assays to identify irritation, sensitisation and phototoxic hazards.

Or continue with email

What does “Verified” mean?

Verified means the claimant’s company affiliation was checked.

Something not right?

Let us know if any information on this page is incorrect or if you have concerns about who manages it.